July/August 2015

Jakafi (ruxolitinib) is the first drug approved by the FDA for the treatment of the chronic bone marrow disease polycythemia vera.

The development and management of a successful data strategy require a team effort.

Preparation for the implementation of USP is a multifaceted process that every pharmacy will face.

A clinic sees improved viral suppression rates as a result of comprehensive medication review, medication synchronization, and patient outreach services.

Significant growth has been seen in specialty medication use in long-term care facilities.

Pharmacy stakeholders must be nimble and responsive to innovations and disruptive trends in the market.

The transition in specialty pharmacy from traditional prescription ordering processes to e-prescribing brings challenges and benefits.

NASP promotes collaboration among specialty pharmacy stakeholders, emphasizing the importance of education and advocacy.

Pharmacy stakeholders who work with electronic health care data need to be vigilant against security breaches.

PCSK9 inhibitors are about to make their debut, and specialty pharmacy is poised to play a key role in their management.